Literature DB >> 28616780

[Is deferment of the time of administration to avoid an aspirin/metamizole interaction by chronic dosing sufficient?]

H Bornemann-Cimenti1, S Fleck2, G Rumpold Seitlinger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28616780     DOI： 10.1007/s00393-017-0332-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  5 in total

1.  Analgesic medication with dipyrone in patients with coronary artery disease: Relation to MACCE.

Authors:  Alina Achilles; Annemarie Mohring; Lisa Dannenberg; Kerstin Piayda; Bodo Levkau; Thomas Hohlfeld; Tobias Zeus; Malte Kelm; Amin Polzin
Journal:  Int J Cardiol       Date:  2017-02-27       Impact factor: 4.164

2.  Prevention of dipyrone (metamizole) induced inhibition of aspirin antiplatelet effects.

Authors:  Amin Polzin; Stefan Richter; Karsten Schrör; Tienush Rassaf; Marc W Merx; Malte Kelm; Thomas Hohlfeld; Tobias Zeus
Journal:  Thromb Haemost       Date:  2015-03-19       Impact factor: 5.249

3.  Dipyrone comedication in aspirin treated stroke patients impairs outcome.

Authors:  Lisa Dannenberg; Vladimir Erschoff; Florian Bönner; Michael Gliem; Sebastian Jander; Bodo Levkau; Malte Kelm; Thomas Hohlfeld; Tobias Zeus; Amin Polzin
Journal:  Vascul Pharmacol       Date:  2016-06-11       Impact factor: 5.773

4.  Dipyrone (metamizole) markedly interferes with platelet inhibition by aspirin in patients with acute and chronic pain: A case-control study.

Authors:  Andrea Schmitz; Larissa Romann; Peter Kienbaum; Goran Pavlaković; Robert Werdehausen; Thomas Hohlfeld
Journal:  Eur J Anaesthesiol       Date:  2017-05       Impact factor: 4.330

Review 5.  Clinical pharmacokinetics of dipyrone and its metabolites.

Authors:  M Levy; E Zylber-Katz; B Rosenkranz
Journal:  Clin Pharmacokinet       Date:  1995-03       Impact factor: 6.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.